Class II · Moderate risk Ongoing
Finasteride NDC# 82187-1003-1 Container Description: The product…
Reason CGMP Deviations
Finasteride Plus 1.25 mg Capsule
Class I — High risk. Reasonable probability of serious harm or death.
Why it was recalled
Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
What was recalled
Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.
- Recalling firm
- MasterPharm LLC
- Origin
- NY, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-1269-2020
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Finasteride recalls
See all
Class II · Moderate risk Ongoing
Finasteride Tablets
Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II · Moderate risk Terminated
Finasteride
Reason cGMP deviations
Class II · Moderate risk Terminated
Finasteride Tablets USP
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Terminated
Finasteride Tablets USP 1 mg
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.